TGFB1 and neoplasm: To evoke EMT in SNU-16 cells and mimic conditions which occur in in vivo tumor microenvironment [31] as well as to promote a sustained EMT and an invasive phenotype [32], cells were treated with TGF-β1 for 3 weeks.